True or false: Refills for benzodiazepines require keeping a record for each refill.

Refills for benzodiazepines require keeping a separate record for each refill due to the controlled nature of these medications. Benzodiazepines are classified as Schedule IV controlled substances under Saskatchewan pharmacy regulations. As such, strict record-keeping is essential to monitor their prescribing and dispensing, to prevent misuse, and to ensure patient safety.

Maintaining a record for each refill enables pharmacists and other healthcare providers to track the patient's medication use closely, helping to identify patterns that may indicate substance misuse or dependency. This requirement supports the overall goal of safeguarding public health while allowing patients who truly need these medications to access them responsibly. Keeping thorough records in this context is not just beneficial; it is a regulatory obligation, ensuring compliance with provincial and federal laws regarding controlled substances.